Vident Advisory’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$472K Buy
1,468
+300
+26% +$89.4K ﹤0.01% 1289
2025
Q4
$302K Sell
1,168
-266
-19% -$60.5K ﹤0.01% 1373
2025
Q3
$326K Buy
1,434
+8
+0.6% +$1.64K ﹤0.01% 1367
2025
Q2
$298K Buy
1,426
+47
+3% +$9.05K ﹤0.01% 1307
2025
Q1
$269K Buy
+1,379
New +$285K ﹤0.01% 1317
2024
Q4
Sell
-995
Closed -$207K 1512
2024
Q3
$207K Buy
+995
New +$200K 0.01% 1307

Other funds holding MSGS

Vident Advisory's MSGS Position: Q1 2026 in Review

Vident Advisory increased its Madison Square Garden (MSGS) stake by 26% in Q1 2026, buying an estimated $89.4K and bringing the position to 1,468 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Vident Advisory first reported a position in MSGS in Q3 2024 and has held it in 6 quarters since. 408 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Vident Advisory held 1,468 shares of Madison Square Garden worth $472K as of Q1 2026.
  • Vident Advisory bought 300 Madison Square Garden shares in Q1 2026, an estimated $89.4K.
  • Madison Square Garden made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1289 holding.
  • Vident Advisory first reported a position in Madison Square Garden in Q3 2024 and has held it in 6 quarters since.
  • 408 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.